Glow
Cellular Regeneration & Skin Renewal
Dosage
70mg
Unit Size
1 Vial
// Add to Cart
70mg
$120.00
23 in stock
What is Glow?
Glow is a recovery-focused regenerative compound formulated to support skin health, cellular renewal, and connective tissue repair. It combines growth factor-stimulating and antioxidant compounds to promote collagen synthesis, reduce oxidative damage, and accelerate the body's natural recovery processes — studied for applications in skin aging, tissue repair, and overall cellular health.
70mg
Dose Per Vial
Collagen+
Primary Target
Recovery
Category
Key Benefits
Skin Renewal
Supports collagen and elastin synthesis, improving skin firmness, texture, and overall radiance.
Tissue Healing
Promotes growth factor-mediated tissue repair, accelerating recovery from physical stress and minor damage.
Cellular Turnover
Enhances cellular renewal processes, replacing aged or damaged cells with healthy, functional ones.
Antioxidant Protection
Reduces oxidative stress in skin and connective tissue, protecting against premature aging and cellular damage.
Joint & Connective Tissue
Supports collagen production in joints, tendons, and cartilage — contributing to flexibility and structural integrity.
Reduced Recovery Time
Supports faster recovery from physical exertion by promoting anti-inflammatory signaling and tissue repair cascades.
How It Works
Growth Factor Pathway Activation
Glow activates TGF-β and other growth factor signaling pathways that regulate collagen synthesis and tissue regeneration.
Collagen Synthesis Upregulation
Stimulates fibroblast activity, increasing production of Type I and Type III collagen — the primary structural proteins in skin and connective tissue.
Oxidative Stress Reduction
Neutralizes reactive oxygen species in skin and connective tissue, reducing inflammation-driven aging and cellular damage.
Cellular Turnover Promotion
Supports the natural cycle of cellular apoptosis and renewal, ensuring damaged or senescent cells are replaced by healthy, functional ones.
Common Protocol (Research Reference)
70 mg
Dose per injection
3–5×/week
Frequency
4–8 wks
Typical cycle length
Research Use Notice
Glow is a research peptide not approved by the FDA for human use. This information is for educational purposes only. Always consult a qualified healthcare professional before considering any peptide protocol.